To address reimbursement challenges associated with long-acting reversible contraception (LARC) in the postpartum period, state Medicaid programs have provided additional payments (“carve-outs”). Implementation has been heterogeneous, with states providing separate payments for the device only, procedure only, or both the device and procedure.
Methods:
Claims data were drawn from 210,994 deliveries in the United States between 2012 and 2018. Using generalized estimating equations, we assess the relationship between Medicaid carve-out policies and the likelihood of LARC placement at (1) 3 days postpartum, (2) 60 days postpartum, and (3) 1 year postpartum, in Medicaid and commercially insured populations.
Results:
Among Medicaid beneficiaries, the likelihood of receiving LARC was higher in states with any carve-out, compared with states without carve-outs, at 3 days (adjusted odds ratio [aOR] 1.49 [95% confidence interval: 1.33–1.67], p < 0.001), 60 days (aOR: 1.40 [95% CI: 1.35–1.46], p < 0.001), and 1 year postpartum (aOR: 1.15 [95% CI: 1.11–1.20], p < 0.001). Adjustments were made for geographic region, seasonality, and patient age. Heterogeneity was observed by carve-out type; device carve-outs were consistently associated with greater likelihood of postpartum LARC placement, compared with states with no carve-outs. Similar trends were observed among commercially insured patients.
Conclusion:
Findings support the effectiveness of Medicaid carve-outs on postpartum LARC provision, particularly for device carve-outs, which were associated with increased postpartum LARC placement at 3 days, 60 days, and 1 year postpartum. This outcome suggests that policies to address cost-related barriers associated with LARC devices may prove most useful in overcoming barriers to immediate postpartum LARC placement, with the overarching aim of promoting reproductive autonomy.
Get full access to this article
View all access options for this article.
References
1.
SenderowiczL, HigginsJ. Reproductive autonomy is nonnegotiable, even in the time of covid-19. Int Perspect Sex Reprod Health, 2020; 46:147–151; doi: 10.1363/intsexrephea.46.2020.0147
2.
PotterJE, HopkinsK, AikenA, et al.Unmet demand for highly effective postpartum contraception in two cities in Texas. Contraception, 2013; 88(3):437; doi: 10.1016/j.contraception.2013.05.031
3.
DeFrancoEA, StamilioDM, BoslaughSE, et al.A short interpregnancy interval is a risk factor for preterm birth and its recurrence. Am J Obstet Gynecol, 2007; 197(3):264.e1–264.e6; doi: 10.1016/j.ajog.2007.06.042
4.
HarneyC, DudeA, HaiderS. Factors associated with short interpregnancy interval in women who plan postpartum LARC: A retrospective study. Contraception, 2017; 95(3):245–250; doi: 10.1016/j.contraception.2016.08.012
5.
AhrensKA, ThomaME, CopenCE, et al.Unintended pregnancy and interpregnancy interval by maternal age, National Survey of Family Growth. Contraception, 2018; 98(1):52–55; doi: 10.1016/j.contraception.2018.02.013
6.
MonizMH, Spector-BagdadyK, HeislerM, et al.Inpatient postpartum long-acting reversible contraception: Care that promotes reproductive justice. Obstet Gynecol, 2017; 130(4):783–787; doi: 10.1097/AOG.0000000000002262
7.
HellerR, CameronS, BriggsR, et al.Postpartum contraception: A missed opportunity to prevent unintended pregnancy and short inter-pregnancy intervals. J Fam Plann Reprod Health Care, 2016; 42(2):93–98; doi: 10.1136/jfprhc-2014-101165
8.
PotterJE, Coleman-MinahanK, WhiteK, et al.Contraception after delivery among publicly insured women in Texas: Use compared with preference. Obstet Gynecol, 2017; 130(2):393–402; doi: 10.1097/AOG.0000000000002136
9.
KroelingerCD, OkorohEM, UesugiK, et al.Immediate postpartum long-acting reversible contraception: Review of insertion and device reimbursement policies. Womens Health Issues, 2021; 31(6):523–531; doi: 10.1016/j.whi.2021.09.001
10.
SteenlandMW, VatsaR, PaceLE, et al.Immediate postpartum long-acting reversible contraceptive use following state-specific changes in hospital Medicaid reimbursement. JAMA Netw Open, 2022; 5(10):E2237918; doi: 10.1001/jamanetworkopen.2022.37918
11.
AikenARA, CreininMD, KaunitzAM, et al.Global fee prohibits postpartum provision of the most effective reversible contraceptives. Contraception, 2014; 90(5):466–467; doi: 10.1016/j.contraception.2014.08.005
12.
MonizM, ChangT, HeislerM, et al.Immediate postpartum long-acting reversible contraception: The time is now. Contraception, 2017; 95(4):335–338; doi: 10.1016/j.contraception.2016.11.007
13.
ZerdenML, TangJH, StuartGS, et al.Barriers to receiving long-acting reversible contraception in the postpartum period. Womens Health Issues, 2015; 25(6):616–621; doi: 10.1016/j.whi.2015.06.004
14.
MonizMH, DaltonVK, DavisMM, et al.Characterization of Medicaid policy for immediate postpartum contraception. Contraception, 2015; 92(6):523–531; doi: 10.1016/j.contraception.2015.09.014
15.
Symphony Health, an ICON plc Company, IDV®. January 1, 2012 to December 31, 2018.
16.
ClementJ, JacobiM, GreenwoodBN. Patient access to chronic medications during the COVID-19 pandemic: Evidence from a comprehensive dataset of US insurance claims. PLoS One, 2021; 16(4):e0249453; doi: 10.1371/journal.pone.0249453
NguyenT, ZiedanE, SimonK, et al.Racial and ethnic disparities in buprenorphine and extended-release naltrexone filled prescriptions during the COVID-19 pandemic. JAMA Netw Open, 2022; 5(6):E2214765; doi: 10.1001/jamanetworkopen.2022.14765
19.
MonizMH, SolimanAB, KolenicGE, et al.Cost sharing and utilization of postpartum intrauterine devices and contraceptive implants among commercially insured women. Womens Health Issues, 2019; 29(6):465–470; doi: 10.1016/j.whi.2019.07.006
20.
OkorohEM, KaneDJ, GeeRE, et al.Policy change is not enough: Engaging provider champions on immediate postpartum contraception. Am J Obstet Gynecol, 2018; 218(6):590.e1–590.e7; doi: 10.1016/j.ajog.2018.03.007
21.
NsiahI, MaliNV, BarnardM, et al.The influence of social determinants of health on the provision of postpartum contraceptives in Medicaid. Healthcare, 2022; 10(2):298; doi: 10.3390/healthcare10020298
O’HaraMW. Postpartum depression: What we know. J Clin Psychol, 2009; 65(12):1258–1269; doi: 10.1002/jclp.20644
24.
DawJR, EckertE, AllenHL, et al.Extending postpartum Medicaid: State and federal policy options during and after covid-19. J Health Polit Policy Law, 2021; 46(3):505–526; doi: 10.1215/03616878-8893585
25.
WangX, PengetnzeYM, EckertE, et al.Extending postpartum Medicaid beyond 60 days improves care access and uncovers unmet needs in a Texas Medicaid Health Maintenance Organization. Front Public Heal, 2022; 10(May):1–7; doi: 10.3389/fpubh.2022.841832
MonizMH, DaltonVK. Reimbursement for immediate postpartum contraception outside the global fee: Improving outcomes and reducing costs for moms and babies. Ann Arbor (MI): University of Michigan Institute for Healthcare Policy and Innovation; 2018. 5p. Available from: https://ihpi.umich.edu/sites/default/files/iplarc_021418.pdf
30.
RomeroL, SappenfieldOR, UesugiK, et al.Review of publicly available state policies for long-acting reversible contraception device reimbursement. J Womens Health, 2022; 31(7):1048–1056; doi: 10.1089/jwh.2021.0361
31.
PalmHC, DegnanJH, BiefeldSD, et al.An initiative to implement immediate postpartum long-acting reversible contraception in rural New Mexico. Am J Obstet Gynecol, 2020; 222(4S):S911.e1-S911–e7; doi: 10.1016/j.ajog.2020.01.027
32.
NeadKT, HinkstonCL, WehnerMR. Cautions when using race and ethnicity in administrative claims data sets. JAMA Health Forum, 2022; 3(7):e221812; doi: 10.1001/jamahealthforum.2022.1812
33.
HillEL, SluskyDJG, GintherDK. Reproductive health care in Catholic-owned hospitals. J Health Econ, 2019; 65:48–62; doi: 10.1016/j.jhealeco.2019.02.005
34.
StulbergDB, JacksonRA, FreedmanLR. Referrals for services prohibited in Catholic health care facilities. Perspect Sex Reprod Health, 2016; 48(3):111–117; doi: 10.1363/48e10216
35.
CartwrightAF, BullingtonBW, AroraKS, et al.Prevalence and county-level distribution of births in Catholic hospitals in the US in 2020. JAMA, 2023; 329(11):937–939; doi: 10.1001/jama.2023.0488
36.
KramerRD, GangnonRE, BurnsME. Provision of immediate postpartum long-acting reversible contraceptives before and after Wisconsin Medicaid’s payment change. Womens Health Issues, 2021; 31(4):317–323; doi: 10.1016/j.whi.2021.02.009
37.
BossickAS, BrownJ, HannaA, et al.Impact of state-level reproductive health legislation on access to and use of reproductive health services and reproductive health outcomes: A systematic scoping review in the affordable care act era. Womens Health Issues, 2021; 31(2):114–121; doi: 10.1016/j.whi.2020.11.005
38.
RappKS, VolpeVV, HaleTL, et al.State–level sexism and gender disparities in health care access and quality in the United States. J Health Soc Behav, 2022; 63(1):2–18; doi: 10.1177/00221465211058153
39.
SmithCW, KreitzerRJ, KaneKA, et al.Contraception deserts: The effects of title X rule changes on access to reproductive health care resources. Pol & Gen, 2022; 18(3):672–707; doi: 10.1017/S1743923X2100009X
40.
SmithM, McCool-MyersM, KottkeMJ. Analysis of postpartum uptake of long-acting reversible contraceptives before and after implementation of Medicaid reimbursement policy. Matern Child Health J, 2021; 25(9):1361–1368; doi: 10.1007/s10995-021-03180-w
41.
CaudilloML, Hurtado-AcunaC, RendallMS, et al.Association of the Delaware contraceptive access now initiative with postpartum LARC use. Matern Child Health J, 2022; 26(8):1657–1666; doi: 10.1007/s10995-022-03433-2
42.
SteenlandMW, PaceLE, SinaikoAD, et al.Association between South Carolina Medicaid’s change in payment for immediate postpartum long-acting reversible contraception and birth intervals. JAMA, 2019; 322(1):76–78; doi: 10.1001/jama.2019.6854
43.
SteenlandMW, PaceLE, SinaikoAD, et al.Medicaid payments for immediate postpartum long-acting reversible contraception: Evidence from South Carolina. Health Aff, 2021; 40(2):334–342; doi: 10.1377/hlthaff.2020.00254
44.
KroelingerCD, WaddellLF, GoodmanDA, et al.Working with state health departments on emerging issues in maternal and child health: Immediate postpartum long-acting reversible contraceptives. J Womens Health, 2015; 24(9):693–701; doi: 10.1089/jwh.2015.5401
RankinKM, KroelingerCD, DeSistoCL, et al.Application of implementation science methodology to immediate postpartum long-acting reversible contraception policy roll-out across states. Matern Child Health J, 2016; 20(Suppl 1):173–179; doi: 10.1007/s10995-016-2002-4
47.
KroelingerCD, MorganIA, DesistoCL, et al.State-identified implementation strategies to increase uptake of immediate postpartum long-acting reversible contraception policies. J Womens Health, 2019; 28(3):346–356; doi: 10.1089/jwh.2018.7083
48.
MonizMH, BonawitzK, WetmoreMK, et al.Implementing immediate postpartum contraception: A comparative case study at 11 hospitals. Implement Sci Commun, 2021; 2(1):42; doi: 10.1186/s43058-021-00136-7
49.
DeSistoCL, EstrichC, KroelingerCD, et al.Using a multi-state learning community as an implementation strategy for immediate postpartum long-acting reversible contraception. Implement Sci, 2017; 12(1):138–139; doi: 10.1186/s13012-017-0674-9
50.
LacyMM, McMurtry BairdS, ScottTA, et al.Statewide quality improvement initiative to implement immediate postpartum long-acting reversible contraception. Am J Obstet Gynecol, 2020; 222(4S):S910.e1-S910–e8; doi: 10.1016/j.ajog.2019.11.1272
51.
ChenM, LindleyA, KimportK, et al.An in-depth analysis of the use of shared decision making in contraceptive counseling. Contraception, 2019; 99(3):187–191; doi: 10.1016/j.contraception.2018.11.009
52.
BullingtonBW, SataA, AroraKS. Shared decision-making: The way forward for postpartum contraceptive counseling. Open Access J Contracept, 2022; 13(August):121–129; doi: 10.2147/oajc.s360833
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
